Press release
Cell Counting Market Share 2022: Trends, Key Players, Industry Analysis and Forecast 2022-2028
The global market for cell counting is projected to have considerable CAGR of around 7.4% during the forecast period. The major factor that driving the global cell counting market is the rising investment by the pharmaceutical companies and research institutes for the cell based research across the globe. This results primarily due to the increasing prevalence of cancer and the need for effective treatment therapy for cancer patients. For instance, in October 2017, the Stem Cell Network (SCN) has introduced a new funding competition of around $100 million, to provide support for high-quality translational and clinical trials in regenerative medicine and stem cell research. The funding is intended to support novel researches that will support to realize economic and health benefits to the Canadians.A full report of Global Cell Counting Market is available at: https://www.omrglobal.com/industry-reports/cell-counting-market
Moreover, the growing popularity of cell culture in drug discovery, cancer treatment, and vaccine production has encourage the funding of cell-based research. However, the funds required for cell-based research is high due to which funding for these researches have been encouraged in a very few of the developed countries such as the US and UK. Decades of investment in research has made the US a one of the leading country in biological and Medical Science. Most of the success is due to the public/private funding partnership such as state governments of developed economies have put forward money in the form of initiatives in order to attract cell research so that the states may gain benefits of this promising technology.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-counting-market
In the US, private funds generally come from pharmaceutical companies that fund trials to list their own products. More than 83% of National Institute of Health (NIH) funds are distributed through competitive grants to over 300,000 scientists employed at universities, medical schools, and other research institutions in all 50 states of the country. For instance, in 2016, the NIH, the largest federal agency, spent half of the biomedical funds on cell-based research. Research supported by NIH has further extended the understanding of the molecular roots of various cancers and led to important awareness as to how microbial communities affect a range of chronic diseases including obesity and diabetes. It has led to the development of innovative technologies and created entirely new global biotechnology and life sciences industries that drive the cell counting market.
The investment in biomedical research funded by NIH has supported discoveries that lowered mortality from various chronic diseases such as cancer and CVD. NIH-funded research is continuing to produce the awareness that is needed for improvements in the healthcare sector in the near future. NIH major research funding was on immunotherapy, which uses human cells to improve cancer treatment options and creating organ-on-a-chip through a series of micro-chambers, fluids, and human cell to stimulate a person's internal organs.Therefore, the funding on cell-based research increases, the opportunities for augmentation of cell counting market are estimated to grow significantly in the near future.
Global Cell Counting Market Segmentation
By Product Type
• Instruments
• Consumables
By Application
• Medical Applications
• Research
• Industrial
By End-User
• Pharmaceuticals and Biotechnology companies
• Research Institutes and CRO
• Hospitals and Diagnostic Laboratories
Global Cell Counting Market - Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Co.
• Bio-Rad Laboratories Inc.
• Boule Diagnostics AB
• Corning Inc.
• Danahar Corp.
• F. Hoffmann-La Roche Ltd.
• HORIBA Group
• Luminex Corp.
• Logos Biosystems, Inc.
• Merck KGaA
• Nexcelom Bioscience LLC
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell Counting Market Share 2022: Trends, Key Players, Industry Analysis and Forecast 2022-2028 here
News-ID: 2634429 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for NIH
AICUP to Congress: NIH/NSF Research Fuels Pennsylvania's Economy
"AICUP TO CONGRESS: NIH/NSF RESEARCH FUELS PENNSYLVANIA'S ECONOMY"
Letter to Pennsylvania Congressional Delegation on Behalf of 85 Independent Nonprofit Colleges and Universities Spotlights the Crucial Role of Research Funding in Modern Life, American Prosperity
For Immediate Release …
Creative Biolabs Shines at the 2024 NIH Research Festival: Showcasing Antibody S …
Creative Biolabs made a splash at the 2024 NIH Research Festival, held from Sept. 23 to 25, as they highlighted their groundbreaking work in antibody discovery and development.
New York, USA - October 9, 2024 - The festival, which featured scientific lectures, poster presentations, and workshops, was a vibrant hub of knowledge exchange, and Creative Biolabs took center stage in presenting their cutting-edge antibody solutions.
Image: https://www.getnews.info/uploads/b920cc86d613e54736218c29e7f29b5b.jpg
One of the standout technologies on…
Omnix Medical Receives NIH Grant for the Development of its Novel Antimicrobial …
-- Funding supports unique approach for fighting multi-drug resistant Acinetobacter baumannii (AB)
-- Clinical trial preparations of OMN6 under way
JERUSALEM, Israel, August 31, 2021 -- Omnix Medical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, has received a grant by the U.S. National Institutes of Health (NIH) for the development of its first-in-class antimicrobial peptide OMN6 targeting Acinetobacter baumannii (AB). Acinetobacter baumannii are multi-drug resistant…
The National Institutes of Health (NIH) Awards Adelphi University Professors Nea …
The National Institutes of Health (NIH) has awarded Adelphi University Associate Professors Brian Stockman, Ph.D. and Melissa VanAlstine-Parris, Ph.D., both in the Department of Chemistry, a federal grant for $310,934. One of the main goals of the project is to immerse undergraduate students into cutting-edge scientific research including hands-on use of NMR spectroscopy instrumentation, medicinal chemistry and Trichomonas vaginalis cell biology. The award became active on June 1, 2017 and…
BARDA, NIH and Janssen to Present on Antimicrobial Resistance at Superbugs USA t …
SMi are delighted to announce the expansion of their antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA, complementing the Group’s Superbugs & Superdrugs European conference which has been running for the past 18 years.
With pending confirmations from PAHO/WHO and Astra Zeneca, SMi Group have worked closely with a panel of speakers to present an agenda that will look to address key issues…
Dr. James Gulley - NCI, NIH to speak at the Cancer Immunotherapy Congress in Bos …
Dr. James Gulley, an internationally recognized expert in cancer immunotherapy has joined the speaker panel for the Cancer Immunotherapy Congress organized by Markets and Markets Conferences. The congress scheduled for 19th – 20th May 2016 in Boston, USA, will gather scientists, academicians and professionals from Pharmaceutical, Bio-pharmaceutical, Bio-technology companies and Research institutes working in Drug Discovery, Drug Screening, Oncology R&D, Cancer Immunotherapy/ Immuno-oncology and Immunotherapy R&D.
Dr. Gulley serves within…